Christopher Twomey
Direktor/Vorstandsmitglied bei TANDEM DIABETES CARE, INC.
Vermögen: 699 525 $ am 30.04.2024
Aktive Positionen von Christopher Twomey
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
TANDEM DIABETES CARE, INC. | Direktor/Vorstandsmitglied | 01.07.2013 | - |
Independent Dir/Board Member | 01.07.2013 | - | |
BIONANO GENOMICS, INC. | Direktor/Vorstandsmitglied | 01.07.2018 | - |
Independent Dir/Board Member | 01.07.2018 | - |
Karriereverlauf von Christopher Twomey
Ehemalige bekannte Positionen von Christopher Twomey
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CADENCE PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.07.2006 | 19.03.2014 |
Independent Dir/Board Member | 24.11.2011 | 19.03.2014 | |
Biosite, Inc. (Massachusetts) | Finanzdirektor/CFO | 01.03.1990 | 01.06.2007 |
Alere San Diego, Inc.
Alere San Diego, Inc. Medical SpecialtiesHealth Technology Alere San Diego, Inc. develops, manufactures, and markets, diagnostic products. The company was founded by Kim D. Blickenstaff and Gunars E. Valkirs on June 28, 1988 and is headquartered in San Diego, CA. | Finanzdirektor/CFO | 01.03.1990 | 01.01.2007 |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Comptroller/Controller/Auditor | 01.10.1981 | 01.03.1990 |
SENOMYX INC. | Direktor/Vorstandsmitglied | 17.03.2006 | - |
Independent Dir/Board Member | 17.03.2006 | - |
Ausbildung von Christopher Twomey
University of California, Santa Barbara | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 9 |
Operativ
Director/Board Member | 4 |
Independent Dir/Board Member | 4 |
Director of Finance/CFO | 2 |
Sektoral
Health Technology | 5 |
Commercial Services | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
TANDEM DIABETES CARE, INC. | Health Technology |
BIONANO GENOMICS, INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
Alere San Diego, Inc.
Alere San Diego, Inc. Medical SpecialtiesHealth Technology Alere San Diego, Inc. develops, manufactures, and markets, diagnostic products. The company was founded by Kim D. Blickenstaff and Gunars E. Valkirs on June 28, 1988 and is headquartered in San Diego, CA. | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
Senomyx, Inc.
Senomyx, Inc. Food: Specialty/CandyConsumer Non-Durables Senomyx, Inc. engages in the development and commercialization of flavor ingredients for the packaged food, beverage, and ingredient supply industries. It develops high intensity sweeteners, savory flavors, bitter taste blockers, and cooling agents. The company was founded by Paul A. Grayson, Lubert Stryer, Yon Chien Tsien, Denis Baylor, Harold McGee, and Charles Zuker on September 16, 1998 and is headquartered in San Diego, CA. | Consumer Non-Durables |
Mallinckrodt Hospital Products, Inc.
Mallinckrodt Hospital Products, Inc. Pharmaceuticals: MajorHealth Technology Mallinckrodt Hospital Products, Inc. operates as a biopharmaceutical company, which develops and commercializes proprietary product candidates used in the hospital setting. The firm offers OFIRMEV (acetaminophen injection), a proprietary intravenous formulation of acetaminophen for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics and the reduction of fever. The company was founded by Theodore R. Schroeder, David A. Socks, and Cam L. Garner on May 26, 2004 and is headquartered in Hazelwood, MO. | Health Technology |
Biosite, Inc. (Massachusetts) |
- Börse
- Insiders
- Christopher Twomey
- Erfahrung